Market News / Story
AlzeCure Pharma to present at Aktiespararna in Stockholm on 14 October
MFN by Modular Finance ·
MFN by Modular Finance reports: AlzeCure Pharma AB (publ) (FN STO: ALZCUR), which develops small-molecule drug candidates for CNS diseases with a focus on Alzheimer’s disease and pain, today announced that the company will present at Aktiespararna’s investor evening “Aktiemarknadens nuläge med Oliver Uutisalo samt AlzeCure Pharma” in Stockholm on Wednesday, 14 October. At the event, AlzeCure’s CEO Martin Jönsson will provide an update on the company and its project portfolio, including…